Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Insmed Inc shares valued at $750,008 were sold by Lewis William on Aug 04 ’25. At $109.81 per share, Lewis William sold 6,830 shares. The insider’s holdings dropped to 233,924 shares worth approximately $26.03 million following the completion of this transaction.
Also, Flammer Martina M.D. sold 8,715 shares, netting a total of over 954,292 in proceeds. Following the sale of shares at $109.50 each, the insider now holds 83,111 shares.
Before that, Lewis William had added 6,830 shares to its account. In a trade valued at $749,801, the Officer bought Insmed Inc shares for $109.78 each.
As published in their initiating research note from Jefferies on May 13, 2025, Insmed Inc [INSM] has been a Buy and the price target has been revised to $105. Analysts at RBC Capital Mkts started covering the stock with ‘”an Outperform”‘ outlook in a report released in late February. As of April 23, 2024, Truist has initiated its “Buy” rating for INSM. Earlier on February 15, 2024, Wolfe Research initiated its rating. Their recommendation was “an Outperform” for INSM stock.
Analyzing INSM Stock Performance
On last trading session, Insmed Inc [NASDAQ: INSM] plunged -0.31% to $111.26. The stock’s lowest price that day was $109.61, but it reached a high of $112.26 in the same session. During the last five days, there has been a surge of approximately 5.78%. Over the course of the year, Insmed Inc shares have jumped approximately 54.94%.
Is Insmed Inc subject to short interest?
Stocks of Insmed Inc saw a sharp steep in short interest on 2025-07-15 dropping by -1.96 million shares to 9.69 million. Data from Yahoo Finance shows that the short interest on 2025-06-13 was 11.65 million shares. A decline of -20.25% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 2.0 of the overall float, the days-to-cover ratio (short ratio) decline to 2.0.
Which companies own the most shares of Insmed Inc (INSM)?
In terms of Insmed Inc share price expectations, FactSet research, analysts set an average price target of 110 in the next 12 months, down nearly -1.44% from the previous closing price of $111.61. Analysts anticipate Insmed Inc stock to reach 110 by 2025, with the lowest price target being 110. In spite of this, 14 analysts ranked Insmed Inc stock as Buy at the end of 2025. On December 08, 2023, Wells Fargo assigned a price target of “an Overweight” to the stock and initiated coverage with a $55.
